Answers are grounded in this paper and cite their sources.
A new anticancer agent based on the conjugation of a photoactivatable Pt(IV) pro-drug to a cyclic RGD-containing peptide is described. Upon visible light irradiation, phototoxicity was induced preferentially in SK-MEL-28 melanoma cancer cells overexpressing αVβ3 integrin compared to control DU-145 human prostate carcinoma cells.
No takes yet. Share an insight, caveat, or question.
Gandioso et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: